<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>UI-ITB-Indonesia: Judging Session</title>
        <link>https://video.igem.org/videos/watch/d4c02c21-ecc8-47cc-90f6-ee6a9006d82e</link>
        <description>Neuroinflammation is increasingly linked to neurological and mental-health disorders, yet anti-inflammatory proteins such as interleukin-10 (IL-10) cannot readily cross the blood-brain barrier (BBB). In Indonesia, where suicide is stigmatized and often untreated, this gap motivated BELL10. We engineered HEK293 cells with a plasmid combining IL-10, CD63, and a TAT-derived peptide, plus an S/MAR region for episomal plasmid retention, to produce IL-10 and explore its delivery via extracellular vesicles. IL-10, secreted by HEK293 cells, reached 126.70 ± 8.73 pg/mL by day eight. Semi-quantitative measurement of exosomes from TEM suggests size of 59nm. The conditioned medium reduced the inflammatory marker TNF-α in inflamed immune cells, though prolonged treatment caused cell death. A pharmacokinetic-pharmacodynamic model of intranasal IL-10 predicted increased claudin-5, with brain entry dominated by direct nose-brain routes. BELL10 is not a proven therapy but an exploratory step toward engineered systems for neuroinflammation, highlighting challenges before biomedical application.</description>
        <lastBuildDate>Sat, 21 Nov 2026 11:01:22 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>UI-ITB-Indonesia: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/d4c02c21-ecc8-47cc-90f6-ee6a9006d82e</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=d4c02c21-ecc8-47cc-90f6-ee6a9006d82e" rel="self" type="application/rss+xml"/>
    </channel>
</rss>